Articles, Newsletters

Thursday, July 23, 2009

FDA Approves Opioid Pain Reliever with Required Risk Reduction Plan

A recent press release from the FDA has indicated that Onsolis has been approved for certain cancer patients. 

Please click here to read the full press release

<< Back to Article Listings